CARRIE INGRAM: Open Payments
NPI 1316210263 · PUNTA GORDA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,129 in 162 payments from 18 companies in 2025. Trend: 2023 $3,403 · 2024 $3,803 · 2025 $3,129
Food & beverage: $3,129
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $308 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $299 |
| Neurocrine BioSciences, Inc. | 10 | $277 |
| Alkermes, Inc. | 14 | $267 |
| ABBVIE INC. | 20 | $249 |
| Lundbeck LLC | 10 | $241 |
| Vanda Pharmaceuticals Inc. | 8 | $222 |
| Otsuka America Pharmaceutical, Inc. | 10 | $206 |
| Collegium Pharmaceutical, Inc. | 10 | $182 |
| Axsome Therapeutics, Inc. | 10 | $160 |
Products named: REXULTI, CAPLYTA, INVEGA SUSTENNA, INGREZZA, VRAYLAR, ARISTADA, FANAPT, Jornay PM.
Industry payments across FL — which companies pay providers there.
